SCHEMBL29916262

SCHEMBL29916262

CCCCCc1ccc(C(=O)NS(=O)(=O)c2cccc(N)n2)c(Oc2c(C)cc(C)cc2C)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 1/20 0.37
ITGAV P06756 1/20 0.37
ITGA2B P08514 1/20 0.37
FLT1 P17948 4/20 0.33
FLT4 P35916 4/20 0.33
KDR P35968 4/20 0.33
SCN9A Q15858 3/20 0.31
CRHR1 P34998 1/20 0.31
NOS2 P35228 1/20 0.31
KCNH2 Q12809 1/20 0.31
GABRP O00591 1/20 0.30
GABRD O14764 1/20 0.30
GABRA1 P14867 1/20 0.30
GABRB1 P18505 1/20 0.30
GABRG2 P18507 1/20 0.30
GABRB3 P28472 1/20 0.30
GABRA5 P31644 1/20 0.30
GABRA3 P34903 1/20 0.30
GABRA2 P47869 1/20 0.30
GABRB2 P47870 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17647642 1.00 ITGB3 (0.37) ITGB3ITGAVITGA2BFLT1FLT4
SCHEMBL29917902 0.92 ITGB3 (0.37) ITGB3ITGAVITGA2BFLT1FLT4
SCHEMBL17648682 0.92 ITGB3 (0.37) ITGB3ITGAVITGA2BFLT1FLT4
SCHEMBL17648601 0.90 FLT1 (0.35) ITGB3ITGAVITGA2BFLT1FLT4
SCHEMBL29916998 0.90 FLT1 (0.35) ITGB3ITGAVITGA2BFLT1FLT4
SCHEMBL17649370 0.89 ITGB3 (0.34) ITGB3ITGAVITGA2BFLT1FLT4
SCHEMBL29917273 0.89 ITGB3 (0.34) ITGB3ITGAVITGA2BFLT1FLT4
SCHEMBL17647992 0.88 ITGB3 (0.39) ITGB3ITGAVITGA2BFLT1FLT4
SCHEMBL29916260 0.88 ITGB3 (0.39) ITGB3ITGAVITGA2BFLT1FLT4
SCHEMBL19439884 0.87 LGALS8 (0.36) EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3798214-B1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMA (US) 2022-09-14 EP claimed